ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $303,205 | +2.7% | 10,572 | -14.2% | 0.00% | 0.0% |
| Q1 2023 | $295,358 | +41.3% | 12,322 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $208,981 | +14.2% | 12,322 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $183,000 | -5.7% | 12,322 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $194,000 | -87.9% | 12,322 | -79.3% | 0.00% | -83.3% |
| Q1 2022 | $1,608,000 | +468.2% | 59,630 | +613.5% | 0.01% | +500.0% |
| Q2 2021 | $283,000 | – | 8,357 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
| DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
| One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
| Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
| ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
| EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
| Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
| MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
| Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |